Trial Profile
A Multi-center, Randomized, Double-blinded Clinical Study to Assess the Effect of Insulin Enriched Formula on Gastrointestinal Tract Maturation in Pre-term Infants.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2021
Price :
$35
*
At a glance
- Drugs ELGN GI (Primary)
- Indications Gastrointestinal disorders; Nutrition disorders
- Focus Therapeutic Use
- Acronyms INFOSUP
- Sponsors Nutrinia
- 01 Sep 2021 Primary endpoint has been met (Number of days to achieve complete enteral feeding (150-160 ml/kg/day)) , according to Results published in the Israel Medical Association Journal: Imaj
- 01 Sep 2021 Results published in the Israel Medical Association Journal: Imaj
- 09 Aug 2016 Status changed from recruiting to discontinued.